$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Anti-inflammatory effect of Euphorbia supina extract in dextran sulfate sodium-induced colitis mice 원문보기

Bioscience, biotechnology, and biochemistry, v.81 no.11, 2017년, pp.2178 - 2185  

Cha, Ji-Yun (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicine Research Institute, Wonkwang University, Iksan, Jeollabuk-do, Republic of Korea) ,  Jeon, Yong-Deok (Department of Oriental Medicine Resources, Chonbuk National University, Iksan, Jeollabuk-do, Republic of Korea) ,  Xin, Mingjie (EastHill Co., Gwonseon-gu, Suwon, Gyoenggi-do, Republic of Korea) ,  Kim, Do-Kuk (National Institute of Horticultural and Herbal Science, RDA, Jeonju, Jeollabuk-do, Republic of Korea) ,  Lee, Hoon-Yeon (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicine Research Institute, Wonkwang University, Iksan, Jeollabuk-do, Republic of Korea) ,  Kim, Bo-Ram (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicine Research Institute, Wonkwang University, Iksan, Jeollabuk-do, Republic of Korea) ,  Hwang, Sung-Woo (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicine Research Institute, Wonkwang University, Iksan, Jeollabuk-do, Republic of Korea) ,  Kim, Dae-Ki (Department of Immunology and Institute of Medical Science, Chonbu) ,  Jin, Jong-Sik ,  Lee, Young-Mi

Abstract AI-Helper 아이콘AI-Helper

AbstractThe aim of this study is to examine the anti-inflammatory effect of Euphorbia supina (ES) ethanol extract in dextran sulfate sodium (DSS)-induced experimental colitis model. ES was per orally administered at different doses of 4 or 20 mg/kg body weight with 5% DSS in drinking water for 7 day...

참고문헌 (39)

  1. J. Immunology Andoh 183 1 687 2009 10.4049/jimmunol.0804169 Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease 

  2. J. Gastroenterol Sands 42 1 16 2007 10.1007/s00535-006-1995-7 Inflammatory bowel disease : past, present, and future 

  3. J. Gastroenterol Mizoguchi 43 1 1 2008 10.1007/s00535-007-2111-3 Inflammatory bowel disease, past, present and future : lessons from animal models 

  4. Inflamm bowel dis Hanauer 12 supple S3 2006 10.1097/01.MIB.0000195385.19268.68 Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities 

  5. Gut Rutgeerts 51 2 152 2002 10.1136/gut.51.2.152 Protagonist: Crohn’s disease recurrence can be prevented after ileal resection 

  6. Digestion Nagura 63 1 12 2001 10.1159/000051905 The immuno-inflammatory mechanism for tissue injury in inflammatory bowel disease and Helicobacter pylori-infected chronic active gastritis. Roles of the mucosal immune system 

  7. Clin Exp Immunol Ludwiczek 138 2 323 2004 10.1111/cei.2004.138.issue-2 Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease 

  8. N. engl. J. Med Podolsky 325 14 417 1991 10.1056/NEJM199110033251406 Inflammatory bowel disease 

  9. Dig Liver Dis Danese 37 11 811 2005 10.1016/j.dld.2005.03.013 Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation 

  10. Int Immunopharmacol Kumar 11 6 724 2011 10.1016/j.intimp.2011.01.022 Embelin ameliorates dextran sodium sulfate-induced colitis in mice 

  11. World J gastroenterol Xu 10 16 2311 2004 10.3748/wjg.v10.i16.2311 Drug therapy for ulcerative colitis 

  12. Keio J Med Matsuoka 63 4 69 2014 10.2302/kjm.2014-0006-RE Fecal microbiota transplantation for gastrointestinal diseases 

  13. World J Gastroenterol Chen 20 42 15657 2014 10.3748/wjg.v20.i42.15657 Enteric microbiota leads to new therapeutic strategies for ulcerative colitis 

  14. Am J Gastroenterol Kelly 109 7 1065 2014 10.1038/ajg.2014.133 Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients 

  15. J Crohns Colitis Langhorst 9 1 86 2015 10.1093/ecco-jcc/jju007 Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases 

  16. Aliment Pharmacol Ther Ng 38 8 854 2013 10.1111/apt.2013.38.issue-8 Systematic review: the efficacy of herbal therapy in inflammatory bowel disease 

  17. World J Gastroenterol Wan 20 39 14099 2014 10.3748/wjg.v20.i39.14099 Advances in treatment of ulcerative colitis with herbs: from bench to bedside 

  18. J Ethnopharmacol Wang 148 2 655 2013 10.1016/j.jep.2013.05.025 Vasorelaxant action of an ethylacetate fraction of Euphorbia humifusa involves NO-cGMP pathway and potassium channels 

  19. Curr Pharm Des Ogata 9 14 1107 2003 10.2174/1381612033455035 Cytokine and anti-cytokine therapies for inflammatory bowel disease 

  20. Annu Rev Med Papadakis 51 589 2000 10.1146/annurev.med.51.1.289 Role of cytokines in the pathogenesis of inflammatory bowel disease 

  21. Gastroenterology Sartor 106 2 533 1994 10.1016/0016-5085(94)90614-9 Cytokines in intestinal inflammation: pathophysiological and clinical considerations 

  22. Gastroenterology Malizia 100 1 150 1991 10.1016/0016-5085(91)90595-C Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease 

  23. Gastroenterology Simmonds 103 1 186 1992 10.1016/0016-5085(92)91112-H Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease 

  24. Gut Rachmilewitz 36 5 718 1995 10.1136/gut.36.5.718 Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease 

  25. Arch Pharm Res Kang 33 1 87 2010 10.1007/s12272-010-2230-x Attenuation of experimental murine colitis by acanthoic acid from Acanthopanax koreanum 

  26. Dig Dis Sci Murthy 38 9 1722 1993 10.1007/BF01303184 Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporine 

  27. Gastroenterology Okayasu 98 3 694 1990 10.1016/0016-5085(90)90290-H A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice 

  28. Curr Mol Pharmacol Dharmani 1 3 195 2008 10.2174/1874467210801030195 Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key 

  29. Evid Based Complement Alternat Med Wu 2011 525462 2011 10.1093/ecam/neq040 Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice 

  30. Clin Immunol Ishiguro 120 3 335 2006 10.1016/j.clim.2006.05.010 Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis 

  31. Gastroenterology Sandborn 122 6 1592 2002 10.1053/gast.2002.33426 Biologic therapy of inflammatory bowel disease 

  32. Paediatr Drugs Rufo 8 5 279 2006 10.2165/00148581-200608050-00002 Current therapy of inflammatory bowel disease in children 

  33. Prostaglandins Other Lipid Mediat Morita 68-69 165 2002 10.1016/S0090-6980(02)00029-1 Distinct functions of COX-1 and COX-2 

  34. Adv Exp Med Biol Lauritsen 371B 1301 1995 Effects of mesalazine on the formation of lipoxygenase and cyclooxygenase products 

  35. Cell Death Differ Perkins 13 5 759 2006 10.1038/sj.cdd.4401838 Good cop, bad cop: the different faces of NF-κB 

  36. Genes Dev Hayden 18 18 2195 2004 10.1101/gad.1228704 Signaling to NF-κB 

  37. Biochim Biophys Acta Kovacs-Nolan 1820 11 1753 2012 10.1016/j.bbagen.2012.07.007 The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation 

  38. Cell Locksley 104 4 487 2001 10.1016/S0092-8674(01)00237-9 The TNF and TNF receptor superfamilies: integrating mammalian biology 

  39. Expert Opin Ther Targets Rose-John 11 5 613 2007 10.1517/14728222.11.5.613 The IL-6/sIL-6R complex as a novel target for therapeutic approaches 

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로